Specifications
| SKU | ISG001472 |
| Brand | Eslizepine |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 800 Mg |
| Shop by Concerns | Epilepsy |
| Gender | Neutral |
| Shop By Goals | Epilepsy Management |
| Ingredient | Eslicarbazepine acetate |
| UPC | 6223004690051 |
| Specialty | Clinically Tested Prescription only |
| Sub Categories | Anti-Epileptic |
| Warning | Do not use as a sole source of nutrition May cause dizziness and drowsiness; avoid driving until you know your response Use in pregnancy or breastfeeding under specialist supervision Use with caution in kidney and liver impairment Risk of hyponatremia |
About the product›
Eslizepine 800 Mg
Description:
Eslizepine 800 mg is a prescription anti-epileptic medicine containing eslicarbazepine, used to help control partial-onset (focal) seizures in adults and adolescents as part of epilepsy management. It belongs to the anticonvulsant class and works by stabilizing overactive electrical activity in the brain, thereby reducing the frequency and intensity of seizures. Eslizepine 800 mg film-coated scored tablets are typically used in combination with other anti-epileptic medicines under strict medical supervision.
Indications:
- Treatment of partial-onset (focal) seizures with or without secondary generalization in adults and adolescents, usually as adjunctive (add-on) therapy.
- Helps reduce seizure frequency and severity in patients diagnosed with epilepsy.
- Used in patients who require high-dose eslicarbazepine (800 mg) as determined by a neurologist or treating physician.
Active Ingredients / Key Components:
- Eslicarbazepine acetate – 800 mg per tablet.
- Inactive ingredients/excipients: Not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.) (may include standard tablet excipients such as fillers, binders, and coating agents; exact composition not available).
Dosage & Administration / How to Use:
- Use only as prescribed by a physician experienced in the treatment of epilepsy.
- Typical adult dosing (general reference): therapy is usually started at a lower dose and gradually increased; 800 mg once daily may be used as a maintenance dose based on clinical response and tolerability, as decided by the doctor.
- Tablets are taken orally once daily, preferably at the same time each day.
- Can be taken with or without food; taking with food may help reduce gastrointestinal discomfort in some patients.
- Swallow the tablet whole with a sufficient amount of water. The scored tablet may be split if a half dose is prescribed, but only as directed by the doctor.
- Do not stop taking Eslizepine 800 mg suddenly without medical advice, as abrupt discontinuation may increase seizure frequency or cause withdrawal seizures. Dose reductions should be gradual under medical supervision.
- If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed dose.
- Always follow the dosing schedule, duration, and adjustments prescribed by your neurologist or healthcare provider.
Clinical Benefits:
- Helps control partial-onset seizures by stabilizing abnormal electrical activity in the brain.
- May reduce seizure frequency and intensity, improving daily functioning and quality of life for people with epilepsy.
- Once-daily dosing supports better treatment adherence and convenience.
- Can be used in combination with other anti-epileptic drugs to optimize seizure control when monotherapy is insufficient.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity or allergy to eslicarbazepine, oxcarbazepine, carbamazepine, or any component of the formulation.
- Use with caution in patients with kidney (renal) impairment; dose adjustment may be required. Severe renal impairment requires special medical assessment.
- Use with caution in patients with liver (hepatic) impairment; periodic monitoring of liver function may be recommended.
- May cause hyponatremia (low blood sodium levels); patients with pre-existing low sodium, on diuretics, or with heart failure should be monitored.
- May cause dizziness, drowsiness, blurred vision, or coordination problems; avoid driving, operating machinery, or performing hazardous tasks until you know how the medicine affects you.
- May increase the risk of suicidal thoughts or behavior in a small number of patients taking anti-epileptic drugs; monitor mood and behavior changes and report them immediately to a doctor.
- Hormonal contraceptives may be less effective when used with some anti-epileptic medicines; women of childbearing potential should discuss effective contraception with their doctor.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Anti-epileptic therapy in pregnancy must be carefully balanced between seizure control and fetal safety.
- Inform your doctor about all other medicines you are taking, including other anti-epileptics, heart medicines, diuretics, and herbal products, to avoid interactions.
- Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; this is a prescription-only medicine.
- Keep out of reach of children.
Side Effects:
- Common side effects may include dizziness, drowsiness, headache, fatigue, nausea, vomiting, double vision, blurred vision, and problems with balance or coordination.
- Other possible effects: tremor, difficulty concentrating, mood changes, irritability, or gastrointestinal discomfort.
- Serious side effects (seek immediate medical attention): signs of severe allergic reaction (rash, itching, swelling of face or tongue, difficulty breathing), severe skin reactions, confusion, seizures worsening, severe dizziness or fainting, signs of low sodium (nausea, headache, confusion, seizures), or yellowing of the skin/eyes (possible liver issues).
- If any side effects are severe, persistent, or concerning, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.
Specifications:
- Form: Scored film-coated tablets.
- Strength: 800 mg eslicarbazepine per tablet.
- Pack size: 20 scored tablets per pack (as per available product name information).
- Route of administration: Oral.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

